ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BIOG Biotech Growth Trust (the) Plc

922.00
15.00 (1.65%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biotech Growth Trust (the) Plc BIOG London Ordinary Share
  Price Change Price Change % Share Price Last Trade
15.00 1.65% 922.00 16:35:19
Open Price Low Price High Price Close Price Previous Close
912.00 908.00 924.00 922.00 907.00
more quote information »
Industry Sector
EQUITY INVESTMENT INSTRUMENTS

Biotech Growth BIOG Dividends History

No dividends issued between 24 Nov 2014 and 24 Nov 2024

Top Dividend Posts

Top Posts
Posted at 02/10/2024 14:10 by sharesoc
Geoff Hsu, General Partner at OrbiMed Capital, will present The Biotech Growth Trust (BIOG) and will discuss its current performance and future strategies on the ShareSoc webinar taking place on the 17th October 2024 at 4 p.m on Zoom. The presentation will be followed by a Q&A session, where you can ask Geoff direct questions.
Posted at 16/11/2022 07:54 by ali47fish
biog update new chair some improvement
Posted at 09/12/2021 11:31 by steeplejack
Questor in Daily Telegraph (9 Dec) recommends BIOG after marked underperformance in 2021.
Posted at 29/11/2021 19:03 by steeplejack
Oh dear,not popular comments i see.Thing is,over the last five years,BIOG is up 57%,over the same period SMT is up 375%.Investment is about opportunity cost as we all know.Now compared with Astra or Pfizer,the underperformance is that much less,over five years the former is up 97% and the latter up 77%.(Generously,i217;m ignoring management costs attaching to BIOG.)I’m really trying to justify why,on its track record,i should continue to hold this trust especially given its rather ‘risk averse’construct.It appears to be a rather broad simple proxy for biotech per se which means even a major success of one of the constituents is unlikely to meaningful alter the NAV.
Posted at 28/7/2021 15:47 by daveoz1
Absolutely ali47fish - I did a lot of investing about 4 months ago and BIOG has been by far the worst performing fund of those that I bought then, especially in the last few days! Finding it very hard to find out reasons for this. Slightly better today, but I'm hoping it improves a LOT more!
Posted at 16/7/2021 10:52 by tomps2
John Rosier mentions Biotech Growth (BIOG) in the latest PIWORLD interview at 12m14s

Watch the video here:

Or listen to the podcast here:
Posted at 09/6/2021 06:11 by steeplejack
2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug.
Posted at 06/3/2021 19:31 by cliff007
Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on.....
Posted at 01/8/2019 15:04 by healthtech
That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance.
Posted at 29/7/2019 15:56 by rogerrail
IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point

Your Recent History

Delayed Upgrade Clock